129 related articles for article (PubMed ID: 27551445)
1. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death.
Sugimoto H; Nakamura M; Yoda H; Hiraoka K; Shinohara K; Sang M; Fujiwara K; Shimozato O; Nagase H; Ozaki T
Cell Death Discov; 2015; 1():15010. PubMed ID: 27551445
[TBL] [Abstract][Full Text] [Related]
2. Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.
Ozaki T; Nakamura M; Ogata T; Sang M; Yoda H; Hiraoka K; Sang M; Shimozato O
Oncotarget; 2016 Nov; 7(44):71937-71950. PubMed ID: 27713122
[TBL] [Abstract][Full Text] [Related]
3. Improvement of gemcitabine sensitivity of p53-mutated pancreatic cancer MiaPaCa-2 cells by RUNX2 depletion-mediated augmentation of TAp73-dependent cell death.
Nakamura M; Sugimoto H; Ogata T; Hiraoka K; Yoda H; Sang M; Sang M; Zhu Y; Yu M; Shimozato O; Ozaki T
Oncogenesis; 2016 Jun; 5(6):e233. PubMed ID: 27294865
[TBL] [Abstract][Full Text] [Related]
4. Impact of RUNX2 gene silencing on the gemcitabine sensitivity of p53‑mutated pancreatic cancer MiaPaCa‑2 spheres.
Sang M; Nakamura M; Ogata T; Sun D; Shimozato O; Nikaido T; Ozaki T
Oncol Rep; 2018 Jun; 39(6):2749-2758. PubMed ID: 29620279
[TBL] [Abstract][Full Text] [Related]
5. Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63.
Ogata T; Nakamura M; Sang M; Yoda H; Hiraoka K; Yin D; Sang M; Shimozato O; Ozaki T
PLoS One; 2017; 12(7):e0179884. PubMed ID: 28671946
[TBL] [Abstract][Full Text] [Related]
6. Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations.
Ozaki T; Yu M; Yin D; Sun D; Zhu Y; Bu Y; Sang M
BMC Cancer; 2018 Mar; 18(1):309. PubMed ID: 29558908
[TBL] [Abstract][Full Text] [Related]
7. Runt-related transcription factor 2 attenuates the transcriptional activity as well as DNA damage-mediated induction of pro-apoptotic TAp73 to regulate chemosensitivity.
Ozaki T; Sugimoto H; Nakamura M; Hiraoka K; Yoda H; Sang M; Fujiwara K; Nagase H
FEBS J; 2015 Jan; 282(1):114-28. PubMed ID: 25331851
[TBL] [Abstract][Full Text] [Related]
8. Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death.
Sugimoto H; Nakamura M; Yoda H; Hiraoka K; Shinohara K; Sang M; Fujiwara K; Shimozato O; Nagase H; Ozaki T
Cell Death Dis; 2015 Oct; 6(10):e1914. PubMed ID: 26469963
[No Abstract] [Full Text] [Related]
9. Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.
Ozaki T; Wu D; Sugimoto H; Nagase H; Nakagawara A
Cell Death Dis; 2013 Apr; 4(4):e610. PubMed ID: 23618908
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway.
Sun D; Yu M; Li Y; Xing H; Gao Y; Huang Z; Hao W; Lu K; Kong C; Shimozato O; Ozaki T; Zhu Y
FEBS Open Bio; 2019 Mar; 9(3):478-489. PubMed ID: 30868056
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of serine/threonine protein phosphatase 5 enhances gemcitabine sensitivity by promoting apoptosis in pancreatic cancer cells
Zhu J; Ji Y; Yu Y; Jin Y; Zhang X; Zhou J; Chen Y
Oncol Lett; 2018 Jun; 15(6):8761-8769. PubMed ID: 29805615
[TBL] [Abstract][Full Text] [Related]
12. Gliotoxin Enhances Autophagic Cell Death via the DAPK1-TAp63 Signaling Pathway in Paclitaxel-Resistant Ovarian Cancer Cells.
Park GB; Jeong JY; Kim D
Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31336860
[TBL] [Abstract][Full Text] [Related]
13. TAp63 plays compensatory roles in p53-deficient cancer cells under genotoxic stress.
Yao JY; Chen JK
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):310-5. PubMed ID: 21075072
[TBL] [Abstract][Full Text] [Related]
14. Plk1 regulates liver tumor cell death by phosphorylation of TAp63.
Komatsu S; Takenobu H; Ozaki T; Ando K; Koida N; Suenaga Y; Ichikawa T; Hishiki T; Chiba T; Iwama A; Yoshida H; Ohnuma N; Nakagawara A; Kamijo T
Oncogene; 2009 Oct; 28(41):3631-41. PubMed ID: 19668228
[TBL] [Abstract][Full Text] [Related]
15. Effect of poly(ADP-ribose)polymerase and DNA topoisomerase I inhibitors on the p53/p63-dependent survival of carcinoma cells.
Montariello D; Troiano A; Di Girolamo D; Beneke S; Calabrò V; Quesada P
Biochem Pharmacol; 2015 Apr; 94(3):212-9. PubMed ID: 25667043
[TBL] [Abstract][Full Text] [Related]
16. miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner.
Zou H; Zou R; Chen K; Zhu C; Tian X; You Y; He X
J Cell Biochem; 2018 Nov; 119(11):9217-9228. PubMed ID: 30105797
[TBL] [Abstract][Full Text] [Related]
17. A feedback loop between RUNX2 and the E3 ligase SMURF1 in regulation of differentiation of human dental pulp stem cells.
Yang F; Xu N; Li D; Guan L; He Y; Zhang Y; Lu Q; Zhang X
J Endod; 2014 Oct; 40(10):1579-86. PubMed ID: 25260729
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis.
Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Acta Pharmacol Sin; 2007 Nov; 28(11):1835-41. PubMed ID: 17959036
[TBL] [Abstract][Full Text] [Related]
19. Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling.
Wang B; Shen C; Li Y; Zhang T; Huang H; Ren J; Hu Z; Xu J; Xu B
Onco Targets Ther; 2019; 12():5751-5765. PubMed ID: 31410021
[No Abstract] [Full Text] [Related]
20. Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells.
Hou Z; Cui Y; Xing H; Mu X
Oncol Lett; 2018 Feb; 15(2):1943-1948. PubMed ID: 29434894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
